Protodioscin (NSC-698 796): Its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel

Planta Medica

Volumn 68, Issue 4, 2002, Pages 297-301

  Hu, Ke ^a   Yao, Xinsheng ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cytotoxicity; Dioscorea collettii var; Dioscoreaceae; Hypoglauca; NCI's anticancer drug screen; NSC 698 796; Protodioscin

Indexed keywords

ANTINEOPLASTIC AGENT; NSC 698796; PROTODIOSCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; DIOSCOREA COLLETTII; DRUG CYTOTOXICITY; DRUG SCREENING; HIGHER PLANT; HUMAN; HUMAN CELL; PHYTOCHEMISTRY; RHIZOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIOSCOREA; DIOSGENIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HUMANS; K562 CELLS; NEOPLASMS; PLANT EXTRACTS; PLANT STEMS; SAPONINS; TUMOR CELLS, CULTURED;

DIOSCOREA; DIOSCOREACEAE; EMBRYOPHYTA;

EID: 0036257506     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-26743     Document Type: Article

References (18)

1. A screening method for antimitotic and antifungal substances using conidia of Pyricularia oryzae, modification and application to tropical marine fungi
2. Antineoplastic agents; I. Three spirostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca
3. Antineoplastic agents: II. Four furostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca
4. A furostanol glycoside from rhizomes of Dioscorea collettii var. hypoglauca
5. A new pregnane glycoside from Dioscorea collettii var. hypoglauca
6. A new pregnane glycoside from Dioscorea collettii var. hypoglauca
7. Status of the NCI preclinical antitumor drug discovery screen
8. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
9. The National Cancer Institute cancer drug discovery and development program
10. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
11. New colorimetric cytotoxicity assay for anticancer drug screening
12. Comparison of in vitro anticancer drug screening data generated with a tertrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
13. Display and analysis of pattern of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
14. Neural computing in cancer drug development: Predicting mechanism of action
15. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen
16. Molecular targets in the National Cancer Institute drug screen
17. The NCI anti-cancer drug screen: A smart screen to identify effectors of novel targets
18. An information-intensive approach to the molecular pharmacology of cancer